Key references in infectious diseases pharmacotherapy.
Most health care practitioners are challenged to maintain knowledge of contemporary practice issues in many therapeutic disciplines. Like many other areas, infectious diseases pharmacotherapy continues to evolve because of new information regarding disease epidemiology and new treatment options. Emerging infections and resistance further compound the need for information. To assist clinicians in identifying such important new information, we compiled a list of key references on infectious diseases pharmacotherapy published over the last 2 years.
Drew
Richard H
RH
School of Medicine, Duke University, Durham, North Carolina, USA. Richard.Drew@Duke.edu
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D021821:Communicable Diseases, Emerging / Q000188:drug therapy*; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D023581:HIV Fusion Inhibitors